Table 2.

Comparison of demographic and clinical characteristics of participants between AF and non-AF group

Subjects	Total (n=8937)	Non-AF group (n=8884)	AF group (n=53)	P value
Age (years)	42.1±13.1	42.1±13.1	56.1±11.6	<0.001
Male, N (%)	4686 (52.4%)	4651 (52.4%)	35 (66.0%)	0.04
BMI (kg/m2)	24.5±3.7	24.5±3.7	25.2±2.8	0.08
Smoking, N (%)	2324 (26.0%)	2308 (26.0%)	16 (30.2%)	0.49
Alcohol use, N (%)	2971 (33.2%)	2951 (33.2%)	20 (37.7%)	0.49
Hypertension, N (%)	2777 (31.1%)	2750 (31.0%)	27 (50.9%)	0.01
Diabetes, N (%)	596 (6.7%)	586 (6.6%)	10 (18.9%)	<0.001
Heart failure, N (%)	7 (0.08%)	6 (0.1%)	1 (1.9%)	<0.001
Gout, N (%)	35 (0.39%)	34 (0.4%)	1 (1.9%)	0.08
Dyslipidaemia, N (%)	3256 (36.4%)	3228 (36.3%)	28 (52.8%)	0.01
MI, N (%)	41 (0.5%)	38 (0.4%)	3 (5.7%)	<0.001
TIA/stroke, N (%)	82 (0.9%)	80 (0.9%)	2 (3.8%)	0.03
Statins use, N (%)	110 (1.2%)	103 (1.2%)	7 (13.2%)	<0.001
Diuretic use, N (%)	51 (0.6%)	50 (0.6%)	1 (1.9%)	0.20
TC (mmol/L)	4.4±0.9	4.4±0.9	4.4±0.9	0.99
TG (mmol/L)	1.6±1.4	1.6±1.3	2.0±1.1	0.37
HDL-c (mmol/L)	1.2±0.3	1.2±0.3	1.1±0.3	0.13
LDL-c (mmol/L)	2.5±0.6	2.5±0.6	2.5±0.5	0.82
FBG (mmol/L)	5.3±1.1	5.3±1.1	5.8±1.3	<0.001
Creatinine (μmol/L)	77.2±16.1	77.1±16.1	80.1±12.3	0.09
eGFR (median) (mL/min/1.73 m2)	97.6±16.3	97.6±16.2	87.8±15.8	<0.001
Hyperuricaemia, N (%)	1197 (13.4%)	1184 (13.3%)	13 (24.5%)	0.02
SUA (mg/dL)	5.0±1.5	5.0±1.5	5.5±1.4	0.01

Values are expressed as mean±SD or numbers (percentage).

AF, atrial fibrillation; BMI, body mass index; eGFR, estimated glomerular filtration rate; FBG, fasting blood glucose; HDL-c, high-density lipoprotein-cholesterol; LDL-c, low-density lipoprotein-cholesterol; MI, myocardial infarction; SUA, serum uric acid; TC, total cholesterol; TG, triglycerides; TIA, transient ischaemic attack.